Monday Thomas will present this study on, March 26, at 1:45 p.m. In La Nouvelle Orleans C.. Advances in clinical cardiology Three studies being presented at the American College of Cardiology’s Advancement in Intervention: i2 Summit 2007 in New Orleans, La., highlight the breadth of research propelling advances in clinical cardiology. Invention in Intervention: i2 Summit can be an annual conference for practicing cardiovascular interventionalists sponsored by the American College of Cardiology in partnership with the Culture for Cardiovascular Angiography and Interventions. One research explores the best interventional and medical treatment for patients with severe coronary syndromes, the next demonstrates the long-lasting promise of nonsurgical methods to the repair of heart valves, and the third highlights a new drug-exercise mixture that, when used in nuclear scanning of the center, not only improves image quality but wins the approval of individuals by reducing unwanted effects also.Fractures can lead to reduced quality of reduction and lifestyle of independence; someone with osteoporosis could become partially disabled or immobilized also, requiring long-term care thereby. In women over age 45, osteoporosis accounts for more days spent in hospital than many other illnesses, including diabetes, myocardial infarction and breast cancers.7 billion in 2050 predicated on the anticipated changes in the demography of European countries. Aclasta is now approved in more than 30 countries for the treating post-menopausal osteoporosis and in more than 60 countries like the US, Canada and the EU for the treatment of Paget’s disease, the second many common metabolic bone disorder. Additional research are ongoing to examine treatment of corticosteroid-induced osteoporosis, male osteoporosis, and avoidance of bone reduction in osteopenic sufferers.